semaglutide alzheimer's disease clinical trial Efficacy and safety of oral 14 mg (flexible dose) in early-stage symptomatic (evoke and evoke+): two phase 3, randomised, placebo-controlled trials Semaglutide ameliorates Alzheimer's disease and

Whether the drugs contribute through additional mechanisms hasn't been established

Hydration needs should be individualized, with most adults requiring 6480 ounces of water daily unless medically restricted

Researchers Link Use of GLP-1 Medications to Lower Risk of Violence A Rutgers study finds that treatments such as Ozempic and Wegovy may diminish the link between impulsivity and violent behavior The use of GLP-1 medications commonly prescribed for weight loss or managing diabetes may have effects that extend beyond metabolic health, including on behaviors linked to violence, according to Rutgers researchers

metoclopramide use should be limited to a maximum of 5 days